The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors-Reference-Cited by-同舟云学术

The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors

Published:2009-12 Issue:6 Volume:16 Page:487-497
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Hedvat Michael,Huszar Dennis,Herrmann Andreas,Gozgit Joseph M.,Schroeder Anne,Sheehy Adam,Buettner Ralf,Proia David,Kowolik Claudia M.,Xin Hong,Armstrong Brian,Bebernitz Geraldine,Weng Shaobu,Wang Lin,Ye Minwei,McEachern Kristen,Chen Huawei,Morosini Deborah,Bell Kirsten,Alimzhanov Marat,Ioannidis Stephanos,McCoon Patricia,Cao Zhu A.,Yu Hua,Jove Richard,Zinda Michael

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference49 articles.

1. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway;Akira;Cell,1994

2. Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer;Berishaj;Breast Cancer Res.,2007

3. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway;Boccaccio;Nature,1998

4. STATs in oncogenesis;Bowman;Oncogene,2000

5. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis;Bowman;Proc. Natl. Acad. Sci. USA,2001

Cited by 464 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitors identify an auxiliary role for mTOR signalling in necroptosis execution downstream of MLKL activation;Biochemical Journal;2024-08-27

2. Targeting cytokine and chemokine signaling pathways for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-22

3. JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma;Science;2024-06-21

4. Disrupting TSLP–TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases;EMBO Molecular Medicine;2024-06-14

5. Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway;Molecular Medicine;2024-05-17